نتائج البحث - P. D. Badman
- يعرض 1 - 1 نتائج من 1
-
1
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer حسب R. Charles Coombes, P. D. Badman, Jingky Lozano-Kühne, X. Liu, Iain R. Macpherson, Ishtiaq Husain Zubairi, Richard D. Baird, Nitzan Rosenfeld, Javier Garciá Corbacho, Nicola Cresti, Ruth Plummer, Andrew J. Armstrong, R. Allerton, Dónal Landers, H. Nicholas, L. McLellan, Andrew Kean Seng Lim, Florent Moulière, Olivier E. Pardo, Veronica Ferguson, Michael J. Seckl
منشور في 2022Artigo
أدوات البحث:
موضوعات ذات صلة
Adverse effect
Anastrozole
Aromatase
Aromatase inhibitor
Breast cancer
Cancer
Clinical endpoint
Clinical trial
Disease
Estrogen receptor
Fulvestrant
Internal medicine
Letrozole
Medicine
Metastatic breast cancer
Oncology
Phases of clinical research
Progressive disease
Response Evaluation Criteria in Solid Tumors
Tolerability